Table 1.
Baseline characteristics of study participants.
| Total Sample (n=300) | OP (n=155) | IOP(n=145) | |
|---|---|---|---|
| Female Gender, n(%) | 113 (37.67) | 62 (40.00) | 51 (35.17) |
| Age, mean (SD) | 46.09 (6.45) | 46.75 (6.10) | 45.38 (.56) |
| Married, n(%) | 31 (10.33) | 15 (9.68) | 16 (11.03) |
| Employed in past 30d, n(%) | 108 (36.00) | 55 (35.48) | 53 (36.55) |
| Years of Education, mean (SD) | 11.48 (1.61) | 11.56 (1.60) | 11.39 (.13) |
| Number of lifetime hospitalizations, mean (SD) | 2.99 (5.06) | 3.00 (4.48) | 2.98 (.47) |
| No previous opiate agonist treatment, n(%) | 92 (30.67) | 41 (26.45) | 51 (35.17) |
| Previous buprenorphine treatment only, n(%) | 87 (29.00) | 47 (30.32) | 40 (27.59) |
| Previous methadone treatment only, n(%) | 55 (18.33) | 30 (19.35) | 25 (17.24) |
| Previous buprenorphine and methadone treatment, n(%) | 66 (22.00) | 37 (23.87) | 29 (20.00) |
| Injection drug user, n(%) | 70 (23.33) | 41(26.45) | 29 (20.00) |
| Cocaine use in last 30d or cocaine+ urine, n(%) | 184 (61.33) | 87 (56.13) | 97 (66.90) |